Exhibit 1.1
RODMAN &
RENSHAW
Dr. William A.
Carter M.D.
Chief Executive
Officer
Hemispherx
Biopharma, Inc.
One Penn
Center
1617 JFK
Boulevard
Philadelphia,
PA 19103
Dear Dr.
Carter:
The purpose of this letter agreement (the
“Agreement”) is to authorize Rodman & Renshaw, LLC
(“Rodman”) to contact one or more institutional
investors to explore the degree of interest, if any, of such
investors in providing funding to Hemispherx Biopharma, Inc. or its
affiliates (the “Company”). This authorization shall be
exclusive to Rodman for a period of 30 days. The Company
may terminate Rodman’s authorization to contact investors
hereunder at any time upon a 3-day written notice. If
the Company chooses to accept any funding, on terms to be mutually
agreed upon by the Company and any such investor(s), then the
Company shall pay to Rodman the fees set forth below if there is
any funding of the Company (a “Financing”) within 6
months of the date of the termination or expiration of this
Agreement by any investors with which Rodman arranged a conference
call or a meeting for the Company during the term of this
Agreement.
In consideration of the services rendered by
Rodman under this Agreement, the Company agrees to pay Rodman a
cash fee payable immediately upon the closing of any portion of the
Financing equal to 5.5% of the aggregate proceeds raised or
committed in such Financing from such investors, plus 5.5% warrant
coverage. In addition, but only if a Financing is
consummated, the Company agrees to reimburse Rodman at closing for
all reasonable travel and other out-of-pocket expenses incurred in
connection with Rodman’s engagement, including the fees and
expenses of Rodman’s counsel, not to exceed $25,000 without
prior written approval by the Company.
The Company hereby makes to Rodman each of the
representations and warranties made by the Company to the
Purchasers in the Securities Purchase Agreement, to be entered into
in connection with the Financing, as though restated in their
entirety herein.
The Company hereby agrees to the indemnification
and other agreements set forth in the Indemnification Provisions
attached hereto as Addendum A , the provisions of which are
incorporated herein by reference and shall survive the termination
or expiration of this Agreement.
This Agreement shall be governed by and
construed in accordance with the laws of the State of New York,
without regard to conflicts of law principles. Any
dispute arising out of this Agreement shall be adjudicated in the
courts of the State of New York or in the federal courts sitting in
the Southern District of New York, and each of the parties hereto
agrees that service of process upon it by registered or certified
mail at its address set forth herein shall be deemed adequate and
lawful. Any rights to trial by jury with respect to any
such dispute are hereby waived by Rodman and the Company. The
Company shall indemnify Rodman against any liabilities arising
under the Securities Act of 1933, as amended, attributable to any
information supplied or omitted to be supplied to any investor by
the Company pursuant to this Agreement. The Company
acknowledges and agrees that Rodman is not and shall not be
construed as a fiduciary of the Company and shall have no duties or
liabilities to shareholders or creditors of the Company or any
other person by virtue of this Agreement or the retention of Rodman
hereunder, all of which are hereby expressly
waived.